A US study of more than a million Medicaid enrollees newly diagnosed with opioid use disorder (OUD), finds most—nearly seven ...

Nitazene was first developed in the 1950s as an analgesic, but was never approved for medical use. Instead, it was “limited to those researching opioid pharmacology,” said Rolling Stone. Nitazene’s ...

America’s overdose crisis isn’t the simple story we’ve been told for years. A new investigation reveals how two key graphs — ...

Opioids are still widely prescribed, but have limited effectiveness and are associated with serious harms. De-prescribing ...

This 3-part series looks at the current evidence for the treatment of SUD, alcohol use disorder, and tobacco use disorder.

By a News Reporter-Staff News Editor at Insurance Daily News-- Investigators publish new report on Opioids. Financial supporters for this research include NIH National Institute on Drug Abuse, Office ...

The following guide offers a detailed overview of several classes of medications that research links to a higher risk of ...

Purdue Pharma L.P. ("Purdue") announced positive preliminary results from a Phase 1 study of tinostamustine in MGMT promoter-unmethylated (uMGMT) glioblastoma (GBM), a form of aggressive brain cancer ...